Bio Path Holdings Stock Price on December 19, 2024
| BPTH Stock | USD 1.14 0.21 15.56% |
Below is the normalized historical share price chart for Bio Path Holdings extending back to January 11, 2006. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Bio Path stands at 1.14, as last reported on the 28th of December, with the highest price reaching 1.32 and the lowest price hitting 1.13 during the day.
If you're considering investing in Bio Stock, it is important to understand the factors that can impact its price. Bio Path is extremely dangerous given 3 months investment horizon. Bio Path Holdings secures Sharpe Ratio (or Efficiency) of 0.0767, which signifies that the company had a 0.0767% return per unit of risk over the last 3 months. We were able to interpolate and analyze data for twenty-eight different technical indicators, which can help you to evaluate if expected returns of 1.35% are justified by taking the suggested risk. Use Bio Path Downside Deviation of 6.7, mean deviation of 7.08, and Risk Adjusted Performance of 0.0685 to evaluate company specific risk that cannot be diversified away.
As of now, Bio Path's Other Stockholder Equity is increasing as compared to previous years. The Bio Path's current Sale Purchase Of Stock is estimated to increase to about 7.8 M, while Total Stockholder Equity is projected to decrease to under 418.9 K. . As of now, Bio Path's Price Fair Value is increasing as compared to previous years. Bio Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 4th of March 2008 | 200 Day MA 1.8536 | 50 Day MA 0.8988 | Beta 0.222 |
Bio |
Sharpe Ratio = 0.0767
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | BPTH | |||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 17.64 actual daily | 96 96% of assets are less volatile |
Expected Return
| 1.35 actual daily | 26 74% of assets have higher returns |
Risk-Adjusted Return
| 0.08 actual daily | 6 94% of assets perform better |
Based on monthly moving average Bio Path is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Bio Path by adding it to a well-diversified portfolio.
Price Book 2.335 | Book Value 0.714 | Enterprise Value 5.3 M | Enterprise Value Ebitda 0.0252 | Shares Float 2.6 M |
Bio Path Main Headline on 19th of December 2024
Bio-Path Holdings Announces Preclinical Testing of BP1001-A ... by finance.yahoo.com
Preclinical Studies Confirmed BP1001-A Mechanism of Action and Therapeutic Potential in Obesity and Type 2 DiabetesHOUSTON, Dec. 19, 2024 -- Bio-Path Holdings, Inc., , a biotechnology company leveraging its proprietary DNAbilize liposomal delivery and antisense technology to develop a portfolio of targeted nucleic acid cancer drugs, today reported that results from preclinical studies of BP1001-A for obesity demonstrated enhanced insulin sensitivity, confirming BP1
Bio Path Valuation on December 19, 2024
It is possible to determine the worth of Bio Path on a given historical date. On December 19, 2024 Bio was worth 3.25 at the beginning of the trading date compared to the closed value of 1.49. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Bio Path stock. Still, in general, we apply an absolute valuation method to find Bio Path's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Bio Path where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Bio Path's related companies.
| Open | High | Low | Close | Volume | |
| 0.69 | 0.73 | 0.65 | 0.67 | 84,885 | |
12/19/2024 | 3.25 | 3.39 | 1.33 | 1.49 | 113,613,162 |
| 1.39 | 1.45 | 1.16 | 1.26 | 3,761,562 |
| Backtest Bio Path | | | Bio Path History | | | Bio Path Valuation | Previous | Next |
Bio Path Trading Date Momentum on December 19, 2024
| On December 20 2024 Bio Path Holdings was traded for 1.26 at the closing time. The top price for the day was 1.45 and the lowest listed price was 1.16 . The trading volume for the day was 3.8 M. The trading history from December 20, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 15.44% . The overall trading delta against the current closing price is 13.42% . |
Bio Path Holdings Fundamentals Correlations and Trends
By evaluating Bio Path's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Bio Path's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Bio financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Bio Path Stock history
Bio Path investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Bio is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Bio Path Holdings will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Bio Path stock prices may prove useful in developing a viable investing in Bio Path
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 478 K | 292.6 K | |
| Net Loss | -9.4 M | -9.9 M |
Bio Path Stock Technical Analysis
Bio Path technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Bio Path Period Price Range
Low | December 28, 2024
| High |
0.00 | 0.00 |
Bio Path Holdings cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Bio Path December 28, 2024 Market Strength
Market strength indicators help investors to evaluate how Bio Path stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Bio Path shares will generate the highest return on investment. By undertsting and applying Bio Path stock market strength indicators, traders can identify Bio Path Holdings entry and exit signals to maximize returns
Bio Path Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Bio Path's price direction in advance. Along with the technical and fundamental analysis of Bio Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Bio to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0685 | |||
| Jensen Alpha | 1.16 | |||
| Total Risk Alpha | 0.7851 | |||
| Sortino Ratio | 0.1855 | |||
| Treynor Ratio | 0.2791 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Bio Stock analysis
When running Bio Path's price analysis, check to measure Bio Path's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bio Path is operating at the current time. Most of Bio Path's value examination focuses on studying past and present price action to predict the probability of Bio Path's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bio Path's price. Additionally, you may evaluate how the addition of Bio Path to your portfolios can decrease your overall portfolio volatility.
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |